Miravant Medical Technologies

Miravant Medical Technologies, formerly PDT, Inc., is engaged in the integrated development of drugs and medical device products for use in PhotoPoint(TM), their proprietary technologies for photodynamic therapy. PhotoPoint is a medical procedure which integrates the use of proprietary light-activated drugs, proprietary light producing devices and light delivery devices to achieve selective photochemical destruction of diseased cells. Miravant Medical Technologies believe that PhotoPoint has the potential to be a safe, cost-effective, minimally invasive primary or adjunctive treatment for indications in a broad number of disease areas, including oncology, ophthalmology, urology, dermatology and cardiovascular disease. Miravant Medical Technologies are currently conducting clinical trials in ophthalmology and oncology. Miravant Medical Technologies current clinical trials are testing our leading drug candidate, SnET2 (tin ethyl etiopurpurin).

Contact Details: 336 Bollay Drive Santa Barbara CA 93117 United States of America Tel: 805 685 9880 Fax: 805 685 2959 Email: WWW: www.pdti.com/

Loading...

Recent Publications by Miravant Medical Technologies:
PhotoPoint photodynamic therapy with local drug delivery eliminates vessel wall cells in arteriovenous graft models. PURPOSE: To demonstrate the feasibility of PhotoPoint photodynamic therapy...	6th December, 2003	Miravant Medical Technologies, 336 Bollay Drive, Santa Barbara, CA	Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):163-8.
PhotoPoint photodynamic therapy inhibits intimal hyperplasia in arteriovenous access grafts. PURPOSE: To evaluate the ability of PhotoPoint photodynamic therapy (PDT)...	6th December, 2003	Miravant Medical Technologies Inc., 336 Bollay Drive, Goleta, CA	Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):147-51.

BioNews Results for Miravant Medical Technologies:
Durango ER Locked Down After Worker Arrived	CBS 4 Denver:  Jul 21 2008 12:42AM Matching: medical technologies
Bioject Developed Canine Melanoma Device for Merial Ltd	NewsRX:  Jul 20 2008 10:25PM Matching: medical technologies
Medtronic Acquires Restore Medical	FDA News:  Jul 18 2008 10:38PM Matching: medical technologies
Biotech incubator UEL cuts staff	Twin Cities Business Journal:  Jul 19 2008 1:43AM Matching: medical technologies
Biojector(R)2000 Data Presented in Vical's Pandemic Influenza DNA Vaccine Human Trial	SmartBrief:  Jul 18 2008 7:09AM Matching: medical technologies
Promote your company here: BioNewsCast - Press Release Distribution	→View more Miravant Medical Technologies news.

Miravant Medical Technologies Patents:
US Patent No.	Title
6783541	Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts
6138046	Dosimetry probe

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 445 times since April 2007, the link to the organisation's website has been followed 100 times

Recent Search Terms used to find this page: news of Miravant in 2008 | Miravant Medical Technologies | med devices | Miravant Medical Technologies | Miravant Medical Technologies | Miravant Medical Technologies | miravant medical technologies | f | t | t | .

Search for more companies in Santa Barbara

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Miravant Medical Technologies